2022
DOI: 10.1016/j.phymed.2022.154431
|View full text |Cite
|
Sign up to set email alerts
|

Anemoside B4 prevents chronic obstructive pulmonary disease through alleviating cigarette smoke-induced inflammatory response and airway epithelial hyperplasia

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 13 publications
(4 citation statements)
references
References 33 publications
0
4
0
Order By: Relevance
“…In this study, the viability of cells treated with 5% and 25% CSE was lower than that of control cells. Wang et al treated macrophages with 1%, 2.5%, 5%, 7.5%, and 10% CSE for 24 h and found that cell viability began to decrease when the CSE concentration was ≥7.5% [ 29 ], whereas another study revealed that 10% CSE reduced cell viability [ 30 ]. This may be related to the different CSE preparation methods employed and cell lines selected in the experiments.…”
Section: Discussionmentioning
confidence: 99%
“…In this study, the viability of cells treated with 5% and 25% CSE was lower than that of control cells. Wang et al treated macrophages with 1%, 2.5%, 5%, 7.5%, and 10% CSE for 24 h and found that cell viability began to decrease when the CSE concentration was ≥7.5% [ 29 ], whereas another study revealed that 10% CSE reduced cell viability [ 30 ]. This may be related to the different CSE preparation methods employed and cell lines selected in the experiments.…”
Section: Discussionmentioning
confidence: 99%
“…Anemoside B4 has shown significant promise in attenuating the increased levels of inflammatory markers, including IL-1β, TGF-β, IL-8, and TNF-α, in human bronchial epithelial cells exposed to cigarette smoke extract (CSE). This is achieved by inhibiting the MAPK/AP-1/TGF-β signaling pathway, thereby preventing chronic pulmonary obstructive disease induced by cigarette smoke ( Ma et al, 2022 ). Isoliquiritigenin effectively reduces inflammation induced by Mycobacterium tuberculosis (Mtb) through the Notch1/NF-κB and MAPK signaling pathways ( Sun et al, 2022 ).…”
Section: Treatment Of Other Lung-related Diseases With Traditional Ch...mentioning
confidence: 99%
“…This treatment strategy focuses on leveraging multiple anti-cancer mechanisms to enhance the inhibition of carcinogenesis, mitigate drug resistance, and alleviate chemotherapy-related side effects [ 24 ]. Pulsatilla chinensis (Bunge) Regel, a well-known traditional Chinese medicine, is recognized for its “blood-cooling” and detoxification properties [ 25 ]. Among its significant active compounds is 23-hydroxybetulinic acid (23-HBA), a pentacyclic triterpenoid extracted from the root of P. chinensis .…”
Section: Introductionmentioning
confidence: 99%